Cargando…

Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report

Neuropsychiatric symptoms, especially acute psychosis (often referred to as myxedema madness or psychosis), are rare but possible clinical presentations of patients with hypothyroidism. A 42-year-old woman with papillary thyroid carcinoma and recent total thyroidectomy had developed flat affect, par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pattaravimonporn, Nutnicha, Chaikijurajai, Thanat, Chamroonrat, Wichana, Sriphrapradang, Chutintorn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647114/ https://www.ncbi.nlm.nih.gov/pubmed/34950002 http://dx.doi.org/10.1159/000520128

Ejemplares similares

Split high‐dose oral levothyroxine treatment as a successful therapy option in myxedema coma
por: Charoensri, Suranut, et al.
Publicado: (2017)

Incidental breast lesion detected by technetium-99m sestamibi scintigraphy in a patient with primary hyperparathyroidism
por: Saowapa, Sakditad, et al.
Publicado: (2019)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

Double jeopardy - pituitary apoplexy complicated by ruptured aneurysm of the internal carotid artery within an adenoma: a case report
por: Pattaravimonporn, Nutnicha, et al.
Publicado: (2022)

Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center
por: Kanokwongnuwat, Wasit, et al.
Publicado: (2022)

Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022)

Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients
por: Ratanapornsompong, Ganista, et al.
Publicado: (2021)

Risperidone and Levothyroxine for Managing “Myxedema Madness”
por: Patel, Rikinkumar S, et al.
Publicado: (2020)

Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
por: An, Jee Hyun, et al.
Publicado: (2016)

De Novo Appearance of Pre-Tibial Myxedema After Radioactive Iodine Therapy for Graves’ Disease
por: Kuriakose, Cijoy K., et al.
Publicado: (2022)

Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease
por: Wiggins, Brandon, et al.
Publicado: (2022)

Myxedema Coma Disguised as Alcohol Withdrawal
por: Pahwa, Dhivya, et al.
Publicado: (2021)

Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2016)

Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022)

SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

Sustained remission of psychotic symptoms secondary to hypothyroidism (myxedema psychosis) after 6 months of treatment primarily with levothyroxine: a case report
por: Chan, Eric C.
Publicado: (2022)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
por: Marina, Michela, et al.
Publicado: (2022)

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
por: Goldsmith, Stanley J.
Publicado: (2017)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
por: Chung, Jae Hoon
Publicado: (2013)

Acute-on-Chronic Kidney Injury in Thyroid Hormone Withdrawal: A Case with Possible Implications for Radioactive Iodine Planning
por: McAninch, Elizabeth A., et al.
Publicado: (2015)

Myxedema Psychosis: Systematic Review and Pooled Analysis
por: Mohamed, Mouhand F H, et al.
Publicado: (2021)

Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic‐Pituitary‐Thyroid Axis in Euthyroid Dogs
por: Ziglioli, V., et al.
Publicado: (2017)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of  Differentiated Thyroid Cancer
por: Slonimsky, Einat, et al.
Publicado: (2020)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

MON-468 Hypoechoic Nodule Is Not Always the Bad Guy: Lessons Learned from a Patient with Subacute Painful Thyroiditis
por: Vorasart, Pakaworn, et al.
Publicado: (2020)

Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
por: Janson, Annika, et al.
Publicado: (2019)

Initial treatment of myxedema coma using oral levothyroxine: a case report from Tanzania
por: Chamba, Nyasatu G, et al.
Publicado: (2022)

Effectiveness and Safety of Levothyroxine Tablets Combined with Iodine-131 in the Treatment of Thyroid Cancer
por: Bai, Yang, et al.
Publicado: (2022)

Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
por: Riachy, Ruba, et al.
Publicado: (2020)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
por: Fordham, Beth A, et al.
Publicado: (2015)

The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018)

ODP532 Fractionated Radioactive Iodine Therapy in Management of Differentiated Thyroid Cancer
por: Khan, Adeel Ahmad, et al.
Publicado: (2022)

Effect of Psychological Intervention on Differentiated Thyroid Cancer Patients in the Treatment with Radioactive Iodine
por: Liu, Yan-Bin, et al.
Publicado: (2023)

A Case Report on Myxedema Madness: Curable Psychosis
por: Parikh, Nimesh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_grsrheuj4frvqjf5qu62qo02ck